Related references
Note: Only part of the references are listed.Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma
F. Galivo et al.
GENE THERAPY (2010)
Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: Implications for sodium iodide symporter gene therapy
Mohan Hingorani et al.
CLINICAL CANCER RESEARCH (2008)
Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer
Timothy Kottke et al.
MOLECULAR THERAPY (2008)
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy
Jian Qiao et al.
NATURE MEDICINE (2008)
Treatment of implanted mammary tumors with recombinant vesicular stomatitis virus targeted to Her2/neu
Ira Bergman et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus
Rosa Maria Diaz et al.
CANCER RESEARCH (2007)
Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy
Uma Thanarajasingam et al.
CANCER RESEARCH (2007)
VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment
J. Qiao et al.
GENE THERAPY (2006)
Killing of normal melanocytes, combined with heat shock protein 70 and CD40L expression, cures large established melanomas
Luis Sanchez-Perez et al.
JOURNAL OF IMMUNOLOGY (2006)
Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
AI Freeman et al.
MOLECULAR THERAPY (2006)
VSV-tumor selective replication and protein translation
GN Barber
ONCOGENE (2005)
Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice
O Ebert et al.
CANCER GENE THERAPY (2005)
Vesicular stomatitis virus: re-inventing the bullet
BD Lichty et al.
TRENDS IN MOLECULAR MEDICINE (2004)
A simple method to cure established tumors by inflammatory killing of normal cells
GA Daniels et al.
NATURE BIOTECHNOLOGY (2004)
Defective translational control facilitates vesicular stomatitis virus oncolysis
S Balachandran et al.
CANCER CELL (2004)
Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity
M Obuchi et al.
JOURNAL OF VIROLOGY (2003)
Genetically engineered vesicular stomatitis virus in gene therapy: Application for treatment of malignant disease
M Fernandez et al.
JOURNAL OF VIROLOGY (2002)
Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma
V Schmitz et al.
HEPATOLOGY (2001)
Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or Myc function and involves the induction of apoptosis
S Balachandran et al.
JOURNAL OF VIROLOGY (2001)
The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus
DF Stojdl et al.
JOURNAL OF VIROLOGY (2000)
In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity
Y Sun et al.
GENE THERAPY (2000)